Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03781778 · ClinicalTrials.gov registry record · Phase 2
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors
A Phase 2 study, sponsored by Fred Hutchinson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03781778 is a Phase 2 study that was terminated before completion, run by Fred Hutchinson Cancer Center. The registered enrollment target is 10 participants.
The verdict
NCT03781778, a Phase 2 study, was terminated before completion, sponsored by Fred Hutchinson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This phase II, randomized pilot trial studies the effect of the consumption of foods made with resistant starch compared to foods made with corn starch on biomarkers that may be related to colorectal cancer progression in stage I-III colorectal cancer survivors. Foods made with resistant starch may beneficially influence markers of inflammation, insulin resistance, and the composition of gut bacteria in colorectal cancer survivors.
Interventions
- OTHER Questionnaire Administration
- OTHER Dietary Intervention (resistant starch)
- OTHER Dietary Intervention (regular starch)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2020-10-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03781778
The ClinicalTrials.gov registry entry for NCT03781778 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03781778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03781778 about?
NCT03781778 is a clinical study titled "Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors". This phase II, randomized pilot trial studies the effect of the consumption of foods made with resistant starch compared to foods made with corn starch on biomarkers that may be related to colorectal cancer progression in stage I-III colorectal cancer survivors. Foods made with resistant starch may ...
What is the current status of trial NCT03781778?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2019-05-07. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT03781778?
The interventions under investigation include: Questionnaire Administration (OTHER), Dietary Intervention (resistant starch) (OTHER), Dietary Intervention (regular starch) (OTHER).
Who is sponsoring clinical trial NCT03781778?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.